Bo Hjorth Bentzen

Bo Hjorth Bentzen

Associate Professor


  1. 2020
  2. Published

    The KCa2 Channel Inhibitor AP30663 Selectively Increases Atrial Refractoriness, Converts Vernakalant-Resistant Atrial Fibrillation and Prevents Its Reinduction in Conscious Pigs

    Diness, J. G., Kirchhoff, J. E., Speerschneider, T., Abildgaard, L., Edvardsson, N., Sorensen, U. S., Grunnet, Morten & Bentzen, Bo Hjorth, 2020, In: Frontiers in Pharmacology. 11, 9 p., 159.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 13529